𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐓𝐫𝐚𝐜𝐞𝐚𝐛𝐢𝐥𝐢𝐭𝐲 𝐢𝐧 𝐍𝐢𝐠𝐞𝐫𝐢𝐚 – 𝐒𝐭𝐚𝐭𝐮𝐬 𝐔𝐩𝐝𝐚𝐭𝐞

A structured 5-Year Implementation Plan has been deployed with phased rollout, starting with high-risk categories.

𝐓𝐫𝐚𝐜𝐞𝐚𝐛𝐢𝐥𝐢𝐭𝐲 𝐀𝐫𝐜𝐡𝐢𝐭𝐞𝐜𝐭𝐮𝐫𝐞

Traceability is designed across the entire distribution chain:

·      Port of Entry – inspection data capture & risk management

·      Central/Zonal Warehouses

·      State Warehouses

·      Healthcare Facilities

·      Recipients (Patients)

Serialization and event reporting enable visibility across nodes, supporting recall management, pharmacovigilance, and anti-counterfeit operations.

Pilot Execution: Narcotics Serialization

#NAFDAC commissioned early 2024 a #Narcotic Drugs Serialization Pilot as a high-risk control phase.

𝟐𝟎𝟐𝟒–𝟐𝟎𝟐𝟓 𝐌𝐢𝐥𝐞𝐬𝐭𝐨𝐧𝐞𝐬

last year #NAFDAC Mandatory adoption of GS1 standards for =pharmaceutical labeling (since 2024)

=Expansion of serialization requirements

=Acceleration of stakeholder onboarding

=Official unveiling of accredited solution providers (July 22, 2025, Lagos)

Continued investment in digital infrastructure

=The second phase of implementation focuses on strengthening serialization, aggregation, and verification across the ecosystem.

Strategic Impact

𝐏𝐫𝐨𝐨𝐟 𝐨𝐟 𝐒𝐲𝐬𝐭𝐞𝐦 𝐏𝐞𝐫𝐟𝐨𝐫𝐦𝐚𝐧𝐜𝐞 – 𝐂𝐎𝐕𝐈𝐃-𝟏𝟗 𝐕𝐚𝐜𝐜𝐢𝐧𝐞 𝐑𝐞𝐜𝐚𝐥𝐥

Yesterday GS1 Nigeria announced a major validation moment:

Using its national 𝐓𝐫𝐚𝐜𝐞𝐚𝐛𝐢𝐥𝐢𝐭𝐲 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐒𝐲𝐬𝐭𝐞𝐦 (𝐓𝐈𝐒) built on GS1 DataMatrix:

·     100% of a compromised COVID-19 vaccine batch traced

·     Distribution points identified in< 1 hour

·     Nationwide escalation initiated immediately

·     Full recall completed safely

This demonstrated real-time response capability at national scale and positioned Nigeria’s TIS as a model for emergency recall management.